A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Opinion Development |
---|---|
Submitter | Sweden |
Submitter email | kemi@kemi.se |
Regulatory programme |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Hazard classes open for commenting | Acute toxicity Reproductive toxicity |
Specific concentration limits at the time of the proposal | Repr. 1B; H360D: 6,5 % <= C < 9 % Repr. 1B; H360Df: C => 9 % Eye Dam. 1; H318: C => 22 % Eye Irrit. 2; H319: 14 % <= C < 22 % |
Proposed specific concentration limits by the dossier submitter | Eye Dam. 1; H318: C =>22 % Eye Irrit. 2; H319: 14 % <= C < 22 % Oral: ATE = 890 mg/kg bw/day Inhalation: ATE = 0.75 mg/L |
Intention timeline
Date of intention | 2020-05-29 |
---|---|
Expected date of submission | 2021-04-04 |
Submitted for accordance check | 2021-04-01 |
Final submission date | 2021-09-24 |
Start of consultation | 2021-11-08 |
Deadline for commenting | 2022-01-21 |
Date of opinion | 2022-09-15 |
Legal deadline for opinion adoption | 2023-03-26 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Comments received |
|
Related substances
No substances related to this record were found in our database.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Nov. 4, 2022
- Status: Opinion Development → Opinion Adopted
Jan. 18, 2023
- Background document: https://echa.europa.eu/documents/10162/c7641799-d752-70cc-51f9-44dd1b96da56
- Comments received: https://echa.europa.eu/documents/10162/5c729ce8-4566-5613-f76d-0679c90a6f01 → https://echa.europa.eu/documents/10162/b4da3184-f094-01bc-dd51-5ef74f1c12ac
- RAC opinion: https://echa.europa.eu/documents/10162/d25c711c-40c4-0ba3-d901-aaf7a78c0154
This version
Oct. 3, 2022
- Date of opinion: 2022-09-15
Feb. 1, 2022
- Comments received: https://echa.europa.eu/documents/10162/5c729ce8-4566-5613-f76d-0679c90a6f01
- Status: Consultation → Opinion Development
Nov. 9, 2021
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/2fc756e3-ac7f-8f18-0a5a-38d3176d9fa5
- CLH report: https://echa.europa.eu/documents/10162/b40538a7-d4b5-d8fb-b488-ceca2f8d4259
- Deadline for commenting: 2022-01-21
- Final submission date: 2021-09-24
- Hazard classes open for commenting: Acute toxicity Reproductive toxicity
- Legal deadline for opinion adoption: 2023-03-26
- Status: Submitted → Consultation
- Start of consultation: 2021-11-08
Oct. 8, 2021
- Harmonised classification at the time of the proposal: Ox. Sol. 2, H272
April 12, 2021
- Specific concentration limits at the time of the proposal: Repr. 1B; H360D: 6,5 % <= C < 9 % Repr. 1B; H360Df: C => 9 % Eye Dam. 1; H318: C => 22 % Eye Irrit. 2; H319: 14 % <= C < 22 %
- Proposed harmonised classification by the dossier submitter: Acute Tox. 3, H331
- Proposed harmonised classification by the dossier submitter: Acute Tox. 4, H332
- Proposed specific concentration limits by the dossier submitter: Removal of current SCLs for toxicity to reproduction → Eye Dam. 1; H318: C =>22 % Eye Irrit. 2; H319: 14 % <= C < 22 % Oral: ATE = 890 mg/kg bw/day Inhalation: ATE = 0.75 mg/L
- Status: Intention → Submitted
- Submitted for accordance check: 2021-04-01